154 results
Page 3 of 8
8-K
EX-99.1
ldksema sdr2
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am
8-K
EX-10.1
13v5h8nr24jax0pi
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-99.1
0i9zd
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
ehysyqir2
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
8-K
EX-99.1
91qg pfh9mt
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm
8-K
EX-99.1
bzk9i vc58
13 Sep 21
Diffusion Pharmaceuticals Issues Letter to Shareholders
4:09pm
8-K
EX-99.1
k53do0kx3 2jumrq
13 Aug 21
Diffusion Pharmaceuticals Reports Q2 Financial Results
4:30pm
8-K
EX-99.1
abw6 e6md
30 Jun 21
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
4:33pm
8-K
EX-99.2
lppc1
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
8-K
EX-99.1
adr724lbp1dzheion5
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am